Ursprung des Netzwerks ersten Grades von Bervin Bouani
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Turenne Capital Partenaires SA
 Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France.
43
| Subsidiary | Investment Managers | 43 |
Antabio SAS
 Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Mablink Bioscience
 Mablink Bioscience Pharmaceuticals: MajorHealth Technology Mablink Bioscience is a biotechnology company based in Lyon, France that develops next-generation antibody-drug conjugates for the treatment of solid tumors. Mablink Bioscience's exclusive PSarlink™ platform is a unique stealth technology that "masks" the hydrophobicity of the cytotoxic drugs by adding a polysarcosine chain to the linker. The French company's pipeline is built on the topoisomerase-I inhibitor exatecan as a payload for current developments. Recently, the company announced the publication of a review article titled “Payload Diversification\: A Key Step in the Development of Antibody–Drug Conjugates” which reviews the history of the successes and failures in ADC payloads and takes a look at the new roads currently explored by the industry. The company was founded in 2018 by Warren Viricel and Jean-Guillaume Lafay, with Jean-Guillaume Lafay serving as CEO since then.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Germitec SA
 Germitec SA Medical SpecialtiesHealth Technology Germitec SA engages in the research, design, and marketing of medical hygiene systems. It develops Antigermix, which is used in disinfecting heat-sensitive medical instruments. The company was founded in 2005 and is headquartered in Ivry-sur-Seine, France.
7
| Holding Company | Medical Specialties | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bervin Bouani
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ALTUR INVESTISSEMENT | Investment Managers | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Investment Officer | |
| Nord Capital Partenaires SAS | Investment Managers | Chief Executive Officer Chief Executive Officer Director/Board Member Private Equity Investor | |
Essling Capital SAS
 Essling Capital SAS Investment ManagersFinance Essling Capital SAS (Essling Capital) is an independent private equity firm founded in 2016 by Frank-Noël Vandenberghe. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor Private Equity Analyst Private Equity Investor | |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| SUPERSONIC IMAGINE | Medical Specialties | Director of Finance/CFO Director/Board Member | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree Masters Business Admin | |
Stryker Spine SAS
 Stryker Spine SAS Medical SpecialtiesHealth Technology Stryker Spine SAS produces spinal implants. The company is headquartered in Cestas, France. | Medical Specialties | Corporate Officer/Principal Chairman | |
| Université Paris Dauphine-PSL | College/University | Graduate Degree Undergraduate Degree | |
Sofimac Innovation SAS
 Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector. | Investment Managers | Private Equity Investor Private Equity Investor | |
Physio-Assist SAS
 Physio-Assist SAS Medical SpecialtiesHealth Technology Physio-Assist SAS develops an expertise in bronchial mucus analysis and clearance. The company was founded by Adrien Mithalal on September 17, 2012 and is headquartered in Aix en Provence, France. | Medical Specialties | Director/Board Member Director/Board Member | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Undergraduate Degree | |
| Renaissance Corporate SAS | Investment Managers | President President | |
Elaia Partners SAS
 Elaia Partners SAS Investment ManagersFinance Elaia Partners SAS (Elaia) is an independent French private equity boutique which was founded in 2002. Named after the Greek word for olive tree, the symbol of resilience, longevity and prosperity, Elaia focuses on software technology companies. The firm is headquartered in Paris and manages Elaia Ventures, a French FCPR fund backed by financial institutions, industrial investors and family offices. | Investment Managers | Private Equity Investor Private Equity Investor | |
EnobraQ SAS
 EnobraQ SAS Chemicals: Major DiversifiedProcess Industries EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
Naxicap Partners SA
 Naxicap Partners SA Investment ManagersFinance Naxicap Partners SA operates as a private equity firm. It invests in hospitals, pharmaceuticals, business services, information technology, textile, and consumer goods sectors. The company was founded in 1995 and is headquartered in Paris, France. | Investment Managers | Chief Investment Officer Private Equity Analyst | |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Chairman Director/Board Member | |
Siparex XAnge Venture SAS
 Siparex XAnge Venture SAS Investment ManagersFinance Siparex XAnge Venture SAS is an Independent Venture Capital firm founded in 1977 by Benjamin Teszner. Siparex XAnge Venture SAS is headquartered in Paris. | Investment Managers | Director/Board Member Private Equity Analyst | |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member | |
| THERACLION | Medical Specialties | Director/Board Member | |
Insight SiP SAS
 Insight SiP SAS SemiconductorsElectronic Technology Insight Sip SAS provides design services and creative packaging solutions. It offers circuit miniaturization and system in package technology that enables product development in increasing functionality. The firm automates the development of the products portability and flexibility of its methodology for future design service solutions. The company was founded by Chris Baratt and Michel Beghin in 2005 and is headquartered in Sophia-Antipolis, France. | Semiconductors | Director/Board Member | |
Galia Gestion SAS
 Galia Gestion SAS Investment ManagersFinance Galia Gestion SAS (Galia Gestion) is a regional French private equity firm which was created in 2002 to provide capital for small- to medium-sized businesses in the Aquitaine, Poitou-Charentes, Limousin and Midi-Pyrénées regions. Located in Bordeaux, Galia Gestion manages the Galia Investissements 1 and Expanso Investissements FCPRs, the Galia PME 1, 2, 3, 4, 5, 6, 7 and 8 FIPs, Galia Poitou Charentes FIP and Galia Venture, a venture capital firm, for institutional investors. | Investment Managers | Private Equity Analyst | |
Flash Therapeutics SAS
 Flash Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Flash Therapeutics SAS provides biotechnology products for medical research. It custom products include lentiviral vectors, non-integrating lentiviral vectors, stable cell line and animal models. The company was founded by Pascale Bouill? in 2005 and is headquartered in Toulouse, France. | Miscellaneous Commercial Services | Director/Board Member | |
France Invest
 France Invest Financial ConglomeratesFinance France Invest is a French association of investors for growth that supports private equity as a lever for business creators and managers to achieve growth. The private company is based in Paris, France and was founded by Maurice Tchenio. The association is at the heart of the economy and aims to share the value created by supporting companies in their innovation and energy transition efforts. | Financial Conglomerates | Director/Board Member | |
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Chief Operating Officer | |
Crédit Mutuel Equity SCR
 Crédit Mutuel Equity SCR Investment ManagersFinance Credit Mutuel Equity SA is the private equity and venture capital subsidiary of Crédit Industriel et Commercial SA, which is ultimately-owned by Groupe Crédit Mutuel. The firm was founded in 1956. It is headquartered in Paris, with additional offices across France, Canada, USA, Switzerland, Germany, and United Kingdom. | Investment Managers | Private Equity Investor | |
Participex Gestion SAS
 Participex Gestion SAS Investment ManagersFinance Participex Gestion SAS is a Private Equity firm, a subsidiary of Vauban Partenaires SA founded in 1974. Participex Gestion SAS is headquartered in Lille, France. | Investment Managers | Private Equity Investor | |
La Redoute SAS
 La Redoute SAS TextilesProcess Industries La Redoute SAS operates as an online platform for electronic shopping. It offers clothing and accessories for men, women, and children. The firm also sells products for health, gardens, homes, and hobbies. Its services include delivery, after-sales, item exchange, and home installation. The company was founded by Joseph Pollet in 1835 and is headquartered in Roubaix, France. | Textiles | Corporate Officer/Principal | |
| Institut Des Etudes Economiques Et Commerciales | College/University | Undergraduate Degree | |
| VEXIM | Medical Specialties | Chief Executive Officer | |
Medtronic France SAS
 Medtronic France SAS Medical/Nursing ServicesHealth Services Medtronic France SAS provides medical equipment and medical technology services. The company was founded by Earl Bakken and Palmer Hermundslie in 1949 and is headquartered in Boulogne-Billancourt, France. | Medical/Nursing Services | Corporate Officer/Principal | |
Stryker Orthopaedics Corp.
 Stryker Orthopaedics Corp. Medical SpecialtiesHealth Technology Part of Stryker Corp., Stryker Orthopaedics Corp. is a company that specializes in orthopedic prosthetic and surgical appliances and supplies. The company is based in Manchester, NH. | Medical Specialties | Corporate Officer/Principal | |
| Participations Epargne Partenaires | Director/Board Member | ||
Stryker Spain Holding SL
 Stryker Spain Holding SL Financial ConglomeratesFinance Part of Stryker Corp., Stryker Spain Holding SL is an investment holding Spanish company. The company is based in Bilbao, Spain. | Financial Conglomerates | Sales & Marketing | |
BrainVectis SAS
 BrainVectis SAS BiotechnologyHealth Technology BrainVectis SAS provides gene therapy services. It develops gene therapy treatments for neurodegenerative diseases by targeting the cholesterol pathway in the brain to restore cholesterol metabolism. The company was founded by Nathalie Cartier-Lacave and Jérôme Becquart in 2015 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
CR Bard (Spain)
 CR Bard (Spain) Medical SpecialtiesHealth Technology CR Bard (Spain) manufactures medical devices. The private company is based in Barcelona, Spain. | Medical Specialties | Chief Executive Officer | |
| AFFLUENT MEDICAL | Medical Specialties | Chairman | |
Truffle Capital SAS
 Truffle Capital SAS Investment ManagersFinance Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris. | Investment Managers | Private Equity Investor | |
Amber Implants
 Amber Implants Medical SpecialtiesHealth Technology Amber Implants is a Dutch med-tech company that specializes in improving the quality of life of patients suffering from vertebral compression fractures (VCF). Amber Implants is based in The Hague, Netherlands. The company's flagship product is the VCfix® spinal system, which is a vertebral body augmentation system designed to provide pain control and stabilization of the spine. The company was founded in 2019 by Ahmadi Mohammad and Banafsheh Sajidi, with Banafsheh Sajidi serving as the CEO since its inception. | Medical Specialties | Chairman | |
Novartis Seeds AG
 Novartis Seeds AG Chemicals: AgriculturalProcess Industries Part of Novartis AG, Novartis Seeds AG is a company that manufactures agro-chemical products. The company is based in Novartis, Switzerland. | Chemicals: Agricultural | Chief Tech/Sci/R&D Officer | |
| Université Fédérale Toulouse Midi-Pyrénées | College/University | Doctorate Degree | |
| GALAPAGOS NV | Biotechnology | Founder | |
| Total China | Director of Finance/CFO | ||
| Institut d'Optique Graduate School | College/University | Undergraduate Degree | |
Cellerix SA
 Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Director/Board Member | |
| SCYNEXIS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ALTRAN TECHNOLOGIES | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| École Centrale Paris | College/University | Undergraduate Degree |
Statistik
International
| Frankreich | 41 |
| Vereinigte Staaten | 4 |
| Spanien | 4 |
| Niederlande | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 18 |
| Finance | 16 |
| Consumer Services | 8 |
| Commercial Services | 5 |
| Process Industries | 4 |
Operativ
| Director/Board Member | 161 |
| Private Equity Investor | 60 |
| Corporate Officer/Principal | 39 |
| Chairman | 32 |
| Private Equity Analyst | 26 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Florian Denis | 35 |
| Mounia Chaoui-Roulleau | 27 |
| Graziano Seghezzi | 26 |
| François Lombard | 19 |
| David Sourdive | 16 |
| Christian Maugey | 14 |
| Olivier Motte | 14 |
| Julie Rachline | 13 |
| Valérie Calenda | 13 |
| Vincent Gardès | 12 |
| Benedikt Timmerman | 11 |
| Benoît Pastour | 10 |
| Patrice Taisson | 8 |
| Hubert Michalowski | 8 |
| Gordon Waldron | 8 |
- Börse
- Insiders
- Bervin Bouani
- Unternehmensverbindungen
